For cervical cancer, a French group reported that the combination of EGFR/HER3 dual antibody and chemoradiotherapy enhanced cancer cell death in cervical squamous cell carcinoma cells in vitro and a mouse model experiment [64]. The gene discussed is ERBB3; the disease is cervical carcinoma.